Synthetic Biology is the engineering of biology:
the deliberate (re)design and construction of novel
biological and biologically based parts, devices and systems to perform new functions for useful purposes,
that draws on principles elucidated from biology and engineering.
ERASynBio aims at promoting the development of synthetic biology by structuring and coordinating national efforts and investment, with the final goal of creating a sound European research community in the field avoiding national fragmentation from the very start.
ERASynBio is an initiative of international funding agencies working together to promote the robust development of Synthetic Biology and to structure and coordinate national efforts and funding programs. The network was created in 2012 and funded as an ERA-Net by the European Commission under FP7 until 2014. From 2015 onwards, ERASynBio will operate as a self-sustainable initiative (i.e. without the financial support of the EC), with most ERA-Net partners continuing their collaboration in the next years.
Along with the 2 joint calls, several supporting measures were initiated by ERASynBio in order to support the development of high quality Synthetic Biology research. One major effort was the development of a Strategic Vision accompanied by a series of targeted recommendations designed to empower national and international funding organizations, policy bodies and other stakeholders.
It is the aim of the ERASynBio initiative to further support joint activities that focus on transnational coordination, capacity building, sharing resources and facilities, and - last but not least - joint calls for proposals in the field of synthetic biology.
Dr. Marion Karrasch-Bott
Phone: +49 2461 61 6245
A report from the IP (Intellectual property) Expert Meeting at the Danish Agency for Science, Technology & Innovation has been published in the Biotechnical Journal (Biotechnol. J. 2015, 10, 236–241): "Synthetic biology and intellectual property rights: Six recommendations"more
You can find an overview of all news articles here.